It is interesting to detect the TCL6 in leukemia-specific MAEs, since it was recently reported that low TCL6 levels were associated with poor survival of B-cell ALL patient, through a link between TCL6, TCL1B, and the AKT1 pathway (Cuadros et al., 2019). Here, TCL1B is linked to leukemia.